Hello, I'm Joseph Mugaanyi, MD.

I'm a PhD candidate in medicine, specializing in liver regeneration, organ preservation, and translational organoid technologies. My research focuses on developing and validating innovative strategies for improving liver viability during hypothermic storage and machine perfusion, using advanced liver-on-a-chip systems, patient-derived organoids, and small animal models.

Citations
208
h-index
10
i10-index
10
Jose MD.

Education

PhD. in Medicine

Ningbo University

SEP 2022 -

Liver-on-a-chip
Organoids
Machine Perfusion
Liver Transplantation
Liver Regeneration

Msc. Surgery

Ningbo University

SEP 2019 - JUN 2022

Liver Transplantation
Liver Regeneration

MBBS

Ningbo University

SEP 2013 - JUN 2019

Skills

Projects

BioFuseDuo

Design & Prototyping a multi-mode machine perfusion device for small mammals livers.

Prototyping
Design
Validation

Organoid BioBank

Curation and Biobanking of PDOs for pancreatic and biliary tract tumors.

Culture
Curation

RAG Medical Assistant AI Agent

A self-hosted AI toolkit for deploying and evaluating specialist AI agents for clinical decision support models.

Prototyping
Design
Validation

Research

Developments and Applications of Liver-on-a-Chip Technology—Current Status and Future Prospects

Joseph Mugaanyi
Jing Huang
Jiongze Fang
Arthur Musinguzi
Caide Lu
Zaozao Chen

Biomedicines

Evaluation of Large Language Model Performance and Reliability for Citations and References in Scholarly Writing: Cross-Disciplinary Study

Joseph Mugaanyi
Liuying Cai
Sumei Cheng
Caide Lu
Jing Huang

Journal of Medical Internet Research

Risk factors for acute rejection in liver transplantation and its impact on the outcomes of recipients

Joseph Mugaanyi
Jinshu Tong
Changjiang Lu
Shuqi Mao
Jing Huang
Caide Lu

Transplant Immunology

A meta-analysis and systematic review of normothermic and hypothermic machine perfusion in liver transplantation

Joseph Mugaanyi
Lei Dai
Changjiang Lu
Shuqi Mao
Jing Huang
Caide Lu

Journal of Clinical Medicine

Undifferentiated pancreatic carcinomas, clinical features and therapeutic options: What we know

Joseph Mugaanyi
Changjiang Lu
Jing Huang
Caide Lu

Cancers